Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis-Reference-Cited by-同舟云学术

Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis

Published:2001-08 Issue:2 Volume:121 Page:382-388
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

González-Abraldes Juan,Albillos Agustin,Bañares Rafael,Del Arbol Luis Ruiz,Moitinho Eduardo,Rodríguez Claudio,González Monica,Escorsell Angels,García-Pagán Juan Carlos,Bosch Jaume

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference35 articles.

1. Pharmacological treatment of portal hypertension: an evidence-based approach;D'Amico;Semin Liver Dis,1999

2. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage;Groszmann;Gastroenterology,1990

3. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis;Merkel;Hepatology,2000

4. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis;Feu;Lancet,1995

5. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis;Schneider;Hepatology,1999

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Renin–Angiotensin System in Liver Disease;International Journal of Molecular Sciences;2024-05-27

2. Carvedilol and Traditional Nonselective Beta Blockers for the Secondary Prophylaxis of Variceal Hemorrhage and Portal Hypertension Related Complications Among Patients with Decompensated Cirrhosis: A Systematic Review and Network Meta-Analysis;2024

3. Management of Stroke in Patients With Chronic Liver Disease: A Practical Review;Stroke;2023-09

4. Dual angiotensin receptor and neprilysin inhibitor reduced portal pressure through peripheral vasodilatation and decreasing systemic arterial pressure in cirrhotic rats;Journal of the Chinese Medical Association;2023-07-18

5. Autoregulation: mediators and renin–angiotensin system in diseases and treatments;Future Journal of Pharmaceutical Sciences;2023-04-07